Yao Wang

Education

M.P.H., epidemiology, Tulane University School of Public Health and Tropical Medicine; B.A., economics, Anhui University of Technology

Summary of Experience

Ms. Wang specializes in health economics and outcomes research (HEOR), with a particular focus on real-world evidence (RWE) generation. She has designed and conducted research to evaluate and compare the clinical, economic, and humanistic impacts of diseases and treatments across a variety of therapeutic areas, including hematology, oncology, rheumatology, dermatology, and cardiology. Her work has covered many different study types, including surveys, chart reviews, qualitative interviews, discrete-choice experiments (DCE), analyses of real-world databases, systematic literature reviews, and indirect comparisons. Ms. Wang’s work has been published in peer-reviewed journals and presented at clinical and economic research conferences.

Selected Publishing

• Real-World Incidence of Adverse Clinical Outcomes Among People With Coronary Artery Disease and/or Peripheral Artery Disease in Relation to Vascular Risk in the United States

  The American Journal of Cardiology, 2023
  2023

  Desai U, Babcock A, Wang Y, Akbarnejad H, Wirtz EL, Laliberte F, Lefebvre P, Kharat A

  HEOR, Epidemiology & Market Access
• Prevalence of post-traumatic stress disorder in the United States: a systematic literature review

  Current Medical Research and Opinion, 2021
  2021

  Schein J, Houle C, Urganus A, Cloutier M, Patterson-Lomba C, Wang Y, King S, Levinson W, Guérin A, Lefebvre P, Davis LL

  HEOR, Epidemiology & Market Access
• Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study

  Frontiers in Medicine, 2021
  2021

  Wang X, Danese D, Brown T, Baldwin J, Sajeev G, Cook EE, Wang Y, Xu C, Hongbo Yang H, Moritz ML

  HEOR, Epidemiology & Market Access
• Prevalence and economic burden of hyperkalemia in the United States Medicare population

  Current Medical Research and Opinion
  2020

  Mu F, Betts KA, Woolley JM, Dua A, Wang Y, Zhong J, Wu EQ

  HEOR, Epidemiology & Market Access
• Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with severe hemophilia A

  Journal of Blood Medicine, 2019
  2019

  Batt K, Gao W, Ayyagari R, Deschaseaux C, Vashi PB, Yao Z, Wang Y, Kessabi S, Klamroth R

  HEOR, Epidemiology & Market Access